Modulation of cisplatinum cytotoxicity by p53: Effect of p53-mediated apoptosis and DNA repair Journal Article
| Authors: | Fan, J.; Bertino, J. R. |
| Article Title: | Modulation of cisplatinum cytotoxicity by p53: Effect of p53-mediated apoptosis and DNA repair |
| Abstract: | A stable transfectant (S2SN7) of p53-null SaOS-2 (human osteosarcoma) cells expressing wild-type p53 under the tight control of a tetracycline- responsive promoter was used to study the functional roles of p53 in cellular response to cisplatinum (CP). When cells were grown in media containing normal concentrations (10%) of serum, induction of p53 by tetracycline withdrawal resulted in an 8-fold decrease in sensitivity to CP. In contrast, when cells were grown in lower serum (1%) media. induction of p53 led to a 10-fold increase in sensitivity to CP. The p53-mediated sensitivity to CP under lower serum conditions was attributed, at least in part, to increased susceptibility of p53-mediated apoptosis. Under lower serum (0.1-1%) but not normal serum conditions, p53 induction correlated with selective down- regulation of bcl-2, an inhibitor of apoptosis. In addition, a host-cell reactivation assay showed that induction of p53 caused a significant increase in repair of CP-induced DNA damage under normal serum but not low serum conditions. These data suggest that growth conditions may modulate and possibly reverse p53-mediated CP sensitivity by altering p53-mediated gene regulation and, as a result, susceptibility to apoptosis. They also suggest that a combined effect of p53-mediated apoptosis and DNA repair may be the ultimate determinant in p53-mediated cellular resistance or sensitivity to chemotherapeutic drugs. |
| Keywords: | controlled study; human cell; cisplatin; antineoplastic agents; dna damage; cell division; dna repair; protein bcl 2; apoptosis; gene expression; down-regulation; tumor cells, cultured; protein p53; regulatory mechanism; dna, neoplasm; tumor suppressor protein p53; gene control; gene induction; drug cytotoxicity; tetracycline; cell protection; drug sensitivity; proto-oncogene proteins c-bcl-2; culture media; humans; human; priority journal; article |
| Journal Title: | Molecular Pharmacology |
| Volume: | 56 |
| Issue: | 5 |
| ISSN: | 0026-895X |
| Publisher: | The American Society for Pharmacology and Experimental Therapeutics |
| Date Published: | 1999-11-01 |
| Start Page: | 966 |
| End Page: | 972 |
| Language: | English |
| PUBMED: | 10531402 |
| PROVIDER: | scopus |
| DOI: | 10.1124/mol.56.5.966 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 16 August 2016 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work